Eriene is a pharmacist with over 16 years of diverse clinicalresearch experience, predominantly within neurological and psychiatric disorders, including pediatric rare diseases. She joined Prevail Therapeutics in 2019 as the Medical Director for the neuronopathic Gaucher disease clinical research program. Prior to joining Prevail, she served as a Sr. Principle Scientist at Hoffmann-La Roche, where she had clinical and scientific responsibilities for multiple research programs from preclinical through Phase 2. Prior to her time at Roche, Eriene worked within Clinical Development at Janssen LP, a division of J&J. She has worked in a variety of healthcare settings, including as a Consultant Pharmacist for the State of NJ, primarily in Greystone Park Psychiatric Hospital. Eriene received her BS and Doctor of Pharmacy from the Ernest B Mario School of Pharmacy at Rutgers University.